Nutrients

Liraglutide may reduce sepsis by changing gut bacteria and their chemicals

Updated

Abstract

Essence

Liraglutide protected septic mice in a microbiota-dependent way and pointed to as a possible mediator or biomarker.

Evidence

A mixed preclinical study combined transcriptomic analysis, a murine CLP model with microbiota depletion and FMT, 16S/metabolomics, cell assays, and an exploratory patient cohort for biomarker correlations.

Caveat

Most efficacy evidence comes from mouse and cell models, while the human cohort supplies correlations with sepsis biomarkers rather than clinical treatment outcomes.

Simplified

Key numbers

34 of 46
Survival Rate Increase
Survival rates in CLP-induced septic mice treated with liraglutide.
R = −0.67
Correlation
Correlation of plasma with procalcitonin in septic patients.
IL-6, IL-1β, TNF-α
Cytokine Reduction
Cytokine levels measured in serum, BALF, and PLF after liraglutide treatment.

Full Text

What this is

  • Liraglutide, a GLP-1 receptor agonist, shows potential in mitigating -induced organ dysfunction.
  • The study investigates liraglutide's effects on gut microbiota and metabolites in a murine model.
  • Findings indicate that liraglutide enhances survival and reduces inflammation, linked to gut microbiota modulation.

Essence

  • Liraglutide improves survival and reduces inflammation in through modulation of gut microbiota and metabolites. emerges as a key metabolite associated with these protective effects.

Key takeaways

  • Liraglutide treatment significantly enhances survival rates in septic mice compared to untreated controls, demonstrating its protective effect against -induced lethality.
  • Liraglutide reduces levels of pro-inflammatory cytokines such as IL-6, IL-1β, and TNF-α in various biological fluids, indicating systemic anti-inflammatory effects.
  • , a metabolite increased by liraglutide, shows potential as an anti-inflammatory agent and correlates negatively with severity biomarkers in patients.

Caveats

  • The specific microbial taxa mediating liraglutide's protective effects remain unidentified, necessitating further research to clarify these mechanisms.
  • 's causal role in mediating liraglutide-induced protection was not directly demonstrated, requiring additional studies for validation.
  • The murine model may not fully represent human complexity, limiting the generalizability of findings to diverse patient populations.

Definitions

  • Sepsis: A life-threatening organ dysfunction caused by a dysregulated host response to infection.
  • GLP-1RA: Glucagon-like peptide-1 receptor agonist, a class of medications used to manage type 2 diabetes and associated conditions.
  • Citrulline: An amino acid derivative linked to immune modulation and vascular health, significant in the context of sepsis.

Simplified

Funding

Competing interests

0 of 6
authors report competing interests
6 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free